181 related articles for article (PubMed ID: 37884207)
1. Development of lung tissue models and their applications.
Petpiroon N; Netkueakul W; Sukrak K; Wang C; Liang Y; Wang M; Liu Y; Li Q; Kamran R; Naruse K; Aueviriyavit S; Takahashi K
Life Sci; 2023 Dec; 334():122208. PubMed ID: 37884207
[TBL] [Abstract][Full Text] [Related]
2. Human pluripotent stem cell-derived lung organoids: Potential applications in development and disease modeling.
Tian L; Gao J; Garcia IM; Chen HJ; Castaldi A; Chen YW
Wiley Interdiscip Rev Dev Biol; 2021 Nov; 10(6):e399. PubMed ID: 33145915
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional models of the lung: past, present and future: a mini review.
Sen C; Freund D; Gomperts BN
Biochem Soc Trans; 2022 Apr; 50(2):1045-1056. PubMed ID: 35411381
[TBL] [Abstract][Full Text] [Related]
4. Organoids as a model system for studying human lung development and disease.
Nadkarni RR; Abed S; Draper JS
Biochem Biophys Res Commun; 2016 May; 473(3):675-82. PubMed ID: 26721435
[TBL] [Abstract][Full Text] [Related]
5. Modeling of Respiratory Diseases Evolving with Fibrosis from Organoids Derived from Human Pluripotent Stem Cells.
Chamorro-Herrero I; Zambrano A
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901843
[TBL] [Abstract][Full Text] [Related]
6. Lung Organoids-The Ultimate Tool to Dissect Pulmonary Diseases?
Bosáková V; De Zuani M; Sládková L; Garlíková Z; Jose SS; Zelante T; Hortová Kohoutková M; Frič J
Front Cell Dev Biol; 2022; 10():899368. PubMed ID: 35912110
[TBL] [Abstract][Full Text] [Related]
7. Use of three-dimensional organoids and lung-on-a-chip methods to study lung development, regeneration and disease.
Gkatzis K; Taghizadeh S; Huh D; Stainier DYR; Bellusci S
Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30262579
[TBL] [Abstract][Full Text] [Related]
8. Authentic Modeling of Human Respiratory Virus Infection in Human Pluripotent Stem Cell-Derived Lung Organoids.
Porotto M; Ferren M; Chen YW; Siu Y; Makhsous N; Rima B; Briese T; Greninger AL; Snoeck HW; Moscona A
mBio; 2019 May; 10(3):. PubMed ID: 31064833
[TBL] [Abstract][Full Text] [Related]
9. Innovative explorations: unveiling the potential of organoids for investigating environmental pollutant exposure.
Zhang Y; Liu K; He H; Xiao H; Fang Z; Chen X; Li H
Environ Sci Pollut Res Int; 2024 Mar; 31(11):16256-16273. PubMed ID: 38342830
[TBL] [Abstract][Full Text] [Related]
10. Pluripotent stem cells for target organ developmental toxicity testing.
Wu X; Chen Y; Kreutz A; Silver B; Tokar EJ
Toxicol Sci; 2024 May; 199(2):163-171. PubMed ID: 38547390
[TBL] [Abstract][Full Text] [Related]
11. Diesel Particulate Matter 2.5 Induces Epithelial-to-Mesenchymal Transition and Upregulation of SARS-CoV-2 Receptor during Human Pluripotent Stem Cell-Derived Alveolar Organoid Development.
Kim JH; Kim J; Kim WJ; Choi YH; Yang SR; Hong SH
Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33202948
[TBL] [Abstract][Full Text] [Related]
12. Generation of Complete Multi-Cell Type Lung Organoids From Human Embryonic and Patient-Specific Induced Pluripotent Stem Cells for Infectious Disease Modeling and Therapeutics Validation.
Leibel SL; McVicar RN; Winquist AM; Niles WD; Snyder EY
Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e118. PubMed ID: 32640120
[TBL] [Abstract][Full Text] [Related]
13. Airway organoids as models of human disease.
van der Vaart J; Clevers H
J Intern Med; 2021 May; 289(5):604-613. PubMed ID: 32350962
[TBL] [Abstract][Full Text] [Related]
14. Human lung epithelial cell cultures for analysis of inhaled toxicants: Lessons learned and future directions.
Hiemstra PS; Grootaers G; van der Does AM; Krul CAM; Kooter IM
Toxicol In Vitro; 2018 Mar; 47():137-146. PubMed ID: 29155131
[TBL] [Abstract][Full Text] [Related]
15. Harnessing three-dimensional (3D) cell culture models for pulmonary infections: State of the art and future directions.
Shah DD; Raghani NR; Chorawala MR; Singh S; Prajapati BG
Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):2861-2880. PubMed ID: 37266588
[TBL] [Abstract][Full Text] [Related]
16. Organoids for toxicology and genetic toxicology: applications with drugs and prospects for environmental carcinogenesis.
Caipa Garcia AL; Arlt VM; Phillips DH
Mutagenesis; 2022 May; 37(2):143-154. PubMed ID: 34147034
[TBL] [Abstract][Full Text] [Related]
17. Perspectives of future lung toxicology studies using human pluripotent stem cells.
Masui A; Hirai T; Gotoh S
Arch Toxicol; 2022 Feb; 96(2):389-402. PubMed ID: 34973109
[TBL] [Abstract][Full Text] [Related]
18. Toxicological evaluation of airborne particulate matter. Are cell culture technologies ready to replace animal testing?
Silvani S; Figliuzzi M; Remuzzi A
J Appl Toxicol; 2019 Nov; 39(11):1484-1491. PubMed ID: 31025406
[TBL] [Abstract][Full Text] [Related]
19. Developments and Opportunities for 3D Bioprinted Organoids.
Ren Y; Yang X; Ma Z; Sun X; Zhang Y; Li W; Yang H; Qiang L; Yang Z; Liu Y; Deng C; Zhou L; Wang T; Lin J; Li T; Wu T; Wang J
Int J Bioprint; 2021; 7(3):364. PubMed ID: 34286150
[TBL] [Abstract][Full Text] [Related]
20. Emerging toolset of three-dimensional pulmonary cell culture models for simulating lung pathophysiology towards mechanistic elucidation and therapeutic treatment of SARS-COV-2 infection.
Ni K; Che B; Yang C; Qin Y; Gu R; Wang C; Luo M; Deng L
Front Pharmacol; 2022; 13():1033043. PubMed ID: 36578545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
